← Leaderboards
Elizabeth Mara Berry-Kravis
Gordon Research Conferences
$15,669,723
Attributed
$45,555,955
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.6M · FY2012–25$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,706,171 · 5
CDC$4,849,784 · 2
By mechanism
UG3$26,526,303 · 1
U01$16,380,128 · 3
R01$2,464,623 · 1
U54$169,901 · 1
R13$15,000 · 1
Top collaborators
- Nancy C Brady5 shared
- Leann Smith Dawalt5 shared
- Craig Erickson5 shared
- Nicole Renee Tartaglia5 shared
- Steven F Warren5 shared
- Leonard J Abbeduto4 shared
- Randi J Hagerman4 shared
- Yong-Hui Jiang3 shared
Most similar at Gordon Research Conferences
Same institution · by research overlap
- Omowunmi A Sadik$168,242
- Jocelyne Diruggiero$10,000
- Elizabeth J Beise$2,472,769
- Steven E Jacobsen$3,373,435
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularDesignAdultChildFragile X SyndromeResponseBehavioralFamilyCognitionGeneticBehaviorSkillsFutureAdolescentPublic Health RelevanceAutism Spectrum DisorderNeuronsParentsLanguagePhenotypeClinical Trials DesignClinical TrialsClinical TreatmentProteins
Grant awards (25)
A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases$10,672,633
UG3 · FY2025 · TR
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2025 · DD · contact PI
BDCRC - Career Enhancement Core$169,901
U54 · FY2025 · HD · contact PI
A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases$10,834,632
UG3 · FY2024 · TR
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2024 · DD · contact PI
A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases$5,019,038
UG3 · FY2023 · TR
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2023 · DD · contact PI
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2022 · DD · contact PI
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2021 · DD · contact PI
The Effects of Parenting on the Development and Behavior of Adolescents with FXS$455,443
R01 · FY2020 · HD
USING LONGITUDINAL DATA TO CHARACTERIZE THE NATURAL HISTORY OF FRAGILE X SYNDROME TO IMPROVE SERVICES$349,999
U01 · FY2020 · DD · contact PI
Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS)$1,405,132
U01 · FY2019 · NS · contact PI
The Effects of Parenting on the Development and Behavior of Adolescents with FXS$457,111
R01 · FY2019 · HD
Fragile X Clinic and Reseach Cooperative Consortium Agreement: component C$99,946
U01 · FY2019 · DD · contact PI
Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS)$3,281,314
U01 · FY2018 · NS · contact PI
The Effects of Parenting on the Development and Behavior of Adolescents with FXS$482,839
R01 · FY2018 · HD
Fragile X Clinic and Reseach Cooperative Consortium Agreement: component C$99,947
U01 · FY2018 · DD · contact PI
Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS)$3,370,427
U01 · FY2017 · NS · contact PI
The Effects of Parenting on the Development and Behavior of Adolescents with FXS$532,500
R01 · FY2017 · HD
Fragile X Clinic and Reseach Cooperative Consortium Agreement: component C$99,946
U01 · FY2017 · DD · contact PI
Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS)$3,473,471
U01 · FY2016 · NS · contact PI
The Effects of Parenting on the Development and Behavior of Adolescents with FXS$536,730
R01 · FY2016 · HD
Fragile X Clinic and Reseach Cooperative Consortium Agreement: component C$99,946
U01 · FY2016 · DD · contact PI
Fragile X Clinic and Reseach Cooperative Consortium Agreement: component C$100,000
U01 · FY2015 · DD · contact PI
2012 Fragile X and Autism-Related Disorders: From Basic Neuroscience to Improved$15,000
R13 · FY2012 · HD · contact PI